Rafael Carbunaru leads Research and Development for Boston Scientific Neuromodulation. He is focused on developing a portfolio of neuromodulation products and technologies that transform patients’ lives, understanding the science of neuromodulation, and creating a culture of meaningful innovation and high performance. His team has developed breakthrough products in spinal cord stimulation for the treatment of chronic pain, deep brain stimulation for movement disorders, and advanced micro stimulation technologies.
Prior to this role, Rafael was the Research & Development Director for Emerging Indications. He led the development of micro stimulation and MRI compatible technologies as well as supported clinical trials in migraine and overactive bladder, among others.
Rafael holds a Ph.D. and M.Sc. in Biomedical Engineering (with concentration in neurostimulation and electromagnetism) from Case Western Reserve University, under the guidance of Dr. Dominque Durand.